Correspondence 0001213900-23-011445 from NYIAX, INC. (CIK 0001679379)
NYIAX, INC. (CIK 0001679379)
Date: Feb. 14, 2023 · CIK: 0001679379 · Accession: 0001213900-23-011445
AI Filing Summary & Sentiment
File numbers found in text: 333-265357
Show Raw Text
CORRESP
1
filename1.htm
February 14, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3561
Attn: Kyle Wiley
Re:
NYIAX, Inc.
Registration Statement on Form S-1
Filed February 13, 2023
File No. 333-265357
Ladies and Gentlemen:
Pursuant to Rule 461, as amended,
the undersigned, as the representative of the prospective underwriters of the proposed offering by NYIAX, Inc. (the “Company”),
hereby join the Company’s request that the effectiveness of the above-referenced Registration Statement (the “Registration
Statement”) be accelerated so that the Registration Statement will become effective at 4:00 p.m., Eastern Time, on Tuesday, February
14, 2023, or as soon thereafter as is practicable, or at such other time as the Company or its counsel, Robinson & Cole LLP, may request
by telephone that such Registration Statement be declared effective.
The undersigned, as the representative
of the prospective underwriters of the proposed offering, advise on behalf of the underwriters that the underwriters have complied and
will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
BOUSTEAD SECURITIES, LLC
By:
/s/ Keith Moore
Name: Keith Moore
Title: Chief Executive Officer